김혜진 (Emory University)님 | 한빛사연구자 > 한빛사

Emory University

최종업데이트 2026.02.12.

Lipid nanoparticle GM-CSF replacement for autoimmune pulmonary alveolar proteinosis
- Proc. Natl. Acad. Sci. USA, Feb 17 2026, 123 (7) | https://doi.org/10.1073/pnas.2511483123
- 2026-02
- 바이오·의료융합
- 한빛사논문
GENRISE-induced superior extracellular vesicles for scalable therapeutic cargo delivery
- Sci. Adv., Oct 24 2025, 11 (43) | https://doi.org/10.1126/sciadv.ady9680
- 2025-10
- 바이오·의료융합
- 한빛사논문
- 김혜진(Emory University)
Lipid nanoparticle screening in nonhuman primates with minimal loss of life
- Nat. Biotechnol., 26 June 2025 | https://doi.org/10.1038/s41587-025-02711-y
- 2025-06
- 바이오·의료융합
- 한빛사논문
- 김혜진(Emory University)
Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys
- Nat. Biotechnol., Nov 22 2024, | https://doi.org/10.1038/s41587-024-02470-2
- 2024-11
- 바이오·의료융합
- 한빛사논문
BRC-mediated RNAi targeting of USE1 inhibits tumor growth in vitro and in vivo
- Biomaterials, Available online 22 November 2019, 119630 | https://doi.org/10.1016/j.biomaterials.2019.119630
- 2019-11
- 의약학
- 한빛사논문
Enzyme-Driven Hasselback-Like DNA-Based Inorganic Superstructures
- Adv. Funct. Mater., Volume 27, Issue 45, December 1, 2017 | DOI: 10.1002/adfm.201704213
- 2017-12
- 한빛사논문

연구자 ID

저자논문